Search

Your search keyword '"Stein, Lance L."' showing total 27 results
Start Over Author "Stein, Lance L."
27 results on '"Stein, Lance L."'

1. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure

Author

Al Attar, Atef, Kosari, Kambiz, Garcia, Richard, Salmastyan, Gevork, Cranford, William, Patel, Preet, Xue, Pei, Mishra, Soumya, Parks, Madison, Flocco, Gianina, Gao, Jing, Wu, Tiffany, Thanneeru, Priya, Reddy, Vikrant, Hurtado, Mariana, Mohamed, Islam, Vyhmeister, Ross, Lopez, Christine R., Campbell, Braidie, Winters, Adam C., Simpson, Mary Ann, Ying, Xiaohan, Hernaez, Ruben, Karvellas, Constantine J., Liu, Yan, Sacleux, Sophie-Caroline, Khemichian, Saro, Stein, Lance L., Shetty, Kirti, Lindenmeyer, Christina C., Boike, Justin R., Simonetto, Douglas A., Rahimi, Robert S., Jalal, Prasun K., Izzy, Manhal, Kriss, Michael S., Im, Gene Y., Lin, Ming V., Jou, Janice H., Fortune, Brett E., Cholankeril, George, Kuo, Alexander, Mahmud, Nadim, Kanwal, Fasiha, Saliba, Faouzi, Sundaram, Vinay, Artzner, Thierry, and Jalan, Rajiv

Published
2023
Full Text
View/download PDF

2. Patients With Acute-on-Chronic Liver Failure Have Greater Healthcare Resource Utilization After Liver Transplantation

Author

Sundaram, Vinay, Lindenmeyer, Christina C., Shetty, Kirti, Rahimi, Robert S., Al-Attar, Atef, Flocco, Gianina, Fortune, Brett E., Gong, Cynthia, Challa, Suryanarayana, Maddur, Haripriya, Jou, Janice H., Kriss, Michael, Stein, Lance L., Xiao, Alex H., Vyhmeister, Ross H., Green, Ellen W., Campbell, Braidie, Piscitello, Andrew J., Cranford, William, Levitsky, Josh, and Karvellas, Constantine J.

Published
2023
Full Text
View/download PDF

5. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure

Author

Hernaez, Ruben, primary, Karvellas, Constantine J., additional, Liu, Yan, additional, Sacleux, Sophie-Caroline, additional, Khemichian, Saro, additional, Stein, Lance L., additional, Shetty, Kirti, additional, Lindenmeyer, Christina C., additional, Boike, Justin R., additional, Simonetto, Douglas A., additional, Rahimi, Robert S., additional, Jalal, Prasun K., additional, Izzy, Manhal, additional, Kriss, Michael S., additional, Im, Gene Y., additional, Lin, Ming V., additional, Jou, Janice H., additional, Fortune, Brett E., additional, Cholankeril, George, additional, Kuo, Alexander, additional, Mahmud, Nadim, additional, Kanwal, Fasiha, additional, Saliba, Faouzi, additional, Sundaram, Vinay, additional, Artzner, Thierry, additional, Jalan, Rajiv, additional, Al Attar, Atef, additional, Kosari, Kambiz, additional, Garcia, Richard, additional, Salmastyan, Gevork, additional, Cranford, William, additional, Patel, Preet, additional, Xue, Pei, additional, Mishra, Soumya, additional, Parks, Madison, additional, Flocco, Gianina, additional, Gao, Jing, additional, Wu, Tiffany, additional, Thanneeru, Priya, additional, Reddy, Vikrant, additional, Hurtado, Mariana, additional, Mohamed, Islam, additional, Vyhmeister, Ross, additional, Lopez, Christine R., additional, Campbell, Braidie, additional, Winters, Adam C., additional, Simpson, Mary Ann, additional, and Ying, Xiaohan, additional

Published
2023
Full Text
View/download PDF

6. Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis

Author

Hassanein, Tarek, primary, McClain, Craig J., additional, Vatsalya, Vatsalya, additional, Stein, Lance L., additional, Flamm, Steven L., additional, Martin, Paul, additional, Cave, Matthew C., additional, Mitchell, Mack, additional, Barton, Bruce, additional, Nagy, Laura, additional, Szabo, Gyongyi, additional, McCullough, Arthur, additional, Dasarathy, Srinivasin, additional, Shah, Jaymin, additional, Blevins, Christina, additional, Scott, Deborah, additional, Krebs, William, additional, Brown, James E., additional, and Lin, WeiQi, additional

Published
2023
Full Text
View/download PDF

9. Patients With Acute-on-Chronic Liver Failure Have Greater Healthcare Resource Utilization After Liver Transplantation

Author

Sundaram, Vinay, primary, Lindenmeyer, Christina C., additional, Shetty, Kirti, additional, Rahimi, Robert S., additional, Al-Attar, Atef, additional, Flocco, Gianina, additional, Fortune, Brett E., additional, Gong, Cynthia, additional, Challa, Suryanarayana, additional, Maddur, Haripriya, additional, Jou, Janice H., additional, Kriss, Michael, additional, Stein, Lance L., additional, Xiao, Alex H., additional, Vyhmeister, Ross H., additional, Green, Ellen W., additional, Campbell, Braidie, additional, Piscitello, Andrew J., additional, Cranford, William, additional, Levitsky, Josh, additional, and Karvellas, Constantine J., additional

Published
2022
Full Text
View/download PDF

12. Hepatic Storage Disorders

Author

Mazhar, Sameer M., primary, Stein, Lance L., additional, Faria, Silvana C., additional, Peterson, Michael R., additional, and Sirlin, Claude B., additional

Published
2011
Full Text
View/download PDF

13. Contributors

Author

Agarwal, Abhishek Rajendra, primary, Aguirre, Diego A., additional, Aher, Pritish, additional, Anderson, Stephan W., additional, Asrani, Ashwin, additional, Banerjee, Arpan K., additional, Bennett, William, additional, Berggruen, Senta, additional, Blake, Michael, additional, Brancatelli, Giuseppe, additional, Cai, Wenli, additional, Cantisani, Vito, additional, Carbognin, Giovanni, additional, Catalano, Onofrio, additional, Chew, Michael, additional, Chowdhry, Aqeel Ahmad, additional, Choy, Garry, additional, Colen, Rivka R., additional, Cronin, Carmel, additional, Dachman, Abraham H., additional, D’Ambrosio, Ugo, additional, Desai, Hemali, additional, D’Onofrio, Mirko, additional, Faria, Silvana C., additional, Fibus, Todd, additional, Flores, Efrén J., additional, Frank, Mark, additional, Galluzzo, Anna, additional, Ganesan, Karthik, additional, Garg, Alpa G., additional, Gasparaitis, Arunas E., additional, Gee, Michael S., additional, Ghosh, Sukanya, additional, Grant, Thomas, additional, Graziani, Rossella, additional, Gulati, Kavita, additional, Gupta, Arti, additional, Hahn, Peter F., additional, Hammond, Nancy A., additional, Hanna, Robert, additional, Harri, Peter A., additional, Harris, Gordon J., additional, Hawes, Donald, additional, Pampaloni, Miguel Hernandez, additional, Ho, Mai-Lan, additional, Holalkere, Nagaraj-Setty, additional, Jambhekar, Kedar, additional, Jankharia, Bijal, additional, Jha, Saurabh, additional, Joshi, Akash, additional, Kalva, Sanjeeva P., additional, R., Avinash Kambadakone, additional, Katz, David P., additional, Kesavarapu, Keerthana, additional, Kim, Danny, additional, Kim, Kyoung Won, additional, Kim, Min Ju, additional, Koch, Marie R., additional, Kulkarni, Kirti, additional, Kulkarni, Naveen M., additional, Kurup, A. Nick, additional, Lala, Somesh, additional, Lall, Chandana G., additional, Lenhart, Dipti K., additional, Liu, Bob, additional, Ma, Xiaozhou, additional, Macari, Michael, additional, Manfredi, Riccardo, additional, Marcantonio, Andrea, additional, Marin, Daniele, additional, Martinez, Jaime, additional, Masrani, Deepa, additional, Mazhar, Sameer M., additional, Mazumdar, Vishakha, additional, McDowell, Jennifer, additional, Mittal, Pardeep, additional, Moore, Michael, additional, Morana, Giovanni, additional, Morani, Ajaykumar, additional, Motton, Massimiliano, additional, Narin, Ozden, additional, Narra, Vamsidhar R., additional, Nikolaidis, Paul, additional, Oto, Aytekin, additional, Pandey, Tarun, additional, Panek, Ralph C., additional, Patton, Heather M., additional, Johnston, Rocio Perez, additional, Perini, Rodolfo F., additional, Peterson, Christine M., additional, Peterson, Michael R., additional, Petralia, Giuseppe, additional, Power, Niall, additional, Prabhakar, Anand M., additional, Prabhakar, Hima B., additional, Prabhakar, Priya D., additional, Prasad, Srinivasa R., additional, Pryma, Daniel A., additional, Rajesh, Arumugam, additional, Rebello, Anuradha S., additional, Rezvani, Maryam, additional, Rivero, Oscar M., additional, Roedl, Johannes B., additional, Rosman, David A., additional, Sahani, Dushyant V., additional, Sainani, Nisha I., additional, Samir, Anthony E., additional, Sandrasegaran, Kumaresan, additional, Santillan, Cynthia S., additional, Sanyal, Rupan, additional, Saunders, Alissa, additional, Scuderi, Richard T., additional, Seale, Melanie, additional, Sebastian, Sunit, additional, Shah, Hemendra, additional, Shah, Shetal N., additional, Shah, Zarine K., additional, Shiehmorteza, Masoud, additional, Singh, Ajay, additional, Singh, Anand, additional, Sirlin, Claude B., additional, Small, William, additional, Soto, Jorge A., additional, Stein, Lance L., additional, Surabhi, Venkateswar R., additional, Taouli, Bachir, additional, Testoni, Marco, additional, Thabet, Ashraf, additional, Tomei, Ernesto, additional, Udeshi, Michelle, additional, Uppot, Raul N., additional, Vaidya, Sujit, additional, Viswamitra, Sanjaya, additional, Walker, T. Gregory, additional, Westra, Sjirk J., additional, Yaghmai, Vahid, additional, Yokoo, Takeshi, additional, and Yoshida, Hiroyuki, additional

Published
2011
Full Text
View/download PDF

14. Risk Factors for Posttransplantation Mortality in Recipients With Grade 3 Acute‐on‐Chronic Liver Failure: Analysis of a North American Consortium.

Author

Sundaram, Vinay, Patel, Sarvanand, Shetty, Kirti, Lindenmeyer, Christina C., Rahimi, Robert S., Flocco, Gianina, Al‐Attar, Atef, Karvellas, Constantine J., Challa, Suryanarayana, Maddur, Harapriya, Jou, Janice H., Kriss, Michael, Stein, Lance L., Xiao, Alex H., Vyhmeister, Ross H., Green, Ellen W., Campbell, Braidie, Cranford, William, Mahmud, Nadim, and Fortune, Brett E.

Published
2022
Full Text
View/download PDF

21. Acute Liver Injury with Severe Coagulopathy in Marasmus Caused by a Somatic Delusional Disorder

Author

Stein, Lance L. and Jesudian, Arun B.

Subjects
Article Subject
Abstract

Marasmus is a severe form of protein-calorie malnutrition characterized by the depletion of fat stores, muscle wasting, and the lack of edema. In developed countries, marasmus is often the result of anorexia nervosa. Abnormal transaminases with liver synthetic dysfunction have rarely been reported with anorexia nervosa. To our knowledge, we report the first detailed case of acute liver injury with severe coagulopathy (INR>1.5) in a patient with marasmus due to self-induced calorie restriction caused by a somatic delusional disorder. This case highlights the severity of liver injury that may occur with significant weight loss from self-induced calorie restriction and the rapid normalization of this injury with treatment. It is important for clinicians to be aware of patterns of acute liver injury in patients with severe protein-calorie malnutrition, regardless of the underlying cause.

Published
2011
Full Text
View/download PDF

22. Editors

Author

Sahani, Dushyant V., Samir, Anthony E., Grajo, Joseph R., Horst, Nicole D., Anvari, Arash, Bajpai, Surabhi, Chen, Luzeng, Dhyani, Manish, Hayano, Koichi, Kilcoyne, Aoife, Kulkarni, Naveen M., McCarthy, Colin J., Price, Melissa, Sewatkar, Rani S., Thomas, Abraham C., Agnello, Francesco, Aguirre, Diego A., Aher, Pritish, Anderson, Stephan W., Asrani, Ashwin, Banerjee, Arpan K., Bennett, William F., Blake, Michael, Brancatelli, Giuseppe, Cantisani, Vito, Carbognin, Giovanni, Catalano, Onofrio, Chew, Michael, Chowdhry, Aqeel Ahmad, Choy, Garry, Colen, Rivka R., Cronin, Carmel, D'Ambrosio, Ugo, D'Onofrio, Mirko, Dachman, Abraham H., Desai, Hemali, Faria, Silvana C., Fibus, Todd, Flores, Efrén J., Frank, Mark, Ganesan, Karthik, Garg, Alpa G., Gasparaitis, Arunas E., Ghosh, Sukanya, Granja, Manuel F., Graziani, Rossella, Hahn, Peter F., Hanna, Robert, Hawes, Donald, Holalkere, Nagaraj-Setty, Jambhekar, Kedar, Jankharia, Bijal, Kalva, Sanjeeva P., Kambadakone, Avinash, Katz, David P., Kesavarapu, Keerthana, Kim, Hansol, Kim, Kyoung Won, Kim, Min Ju, Kulkarni, Kirti, Kurup, A. Nick, Lala, Somesh, Lall, Chandana G., Lee, Leslie K., Lenhart, Dipti K., Liu, Bob, Ma, Xiaozhou, Macari, Michael, Manfredi, Riccardo, Marcantonio, Andrea, Marin, Daniele, Masrani, Deepa, Mazhar, Sameer M., Mazumdar, Vishakha, Mittal, Pardeep, Moore, Michael, Morana, Giovanni, Morani, Ajaykumar, Motton, Massimiliano, Narin, Ozden, Narra, Vamsi R., Oto, Aytekin, Pandey, Tarun, Panek, Ralph C., Patton, Heather M., Perini, Rodolfo F., Peterson, Michael R., Petralia, Giuseppe, Power, Niall, Prabhakar, Anand M., Prabhakar, Hima B., Prabhakar, Priya D., Prasad, Srinivasa R., Pryma, Daniel A., Rajesh, Arumugam, Rebello, Anuradha S., Rivero, Oscar M., Roedl, Johannes B., Rosman, David A., Sainani, Nisha I., Sandrasegaran, Kumaresan, Santillan, Cynthia S., Sanyal, Rupan, Saunders, Alissa, Scuderi, Richard T., Seale, Melanie, Sebastian, Sunit, Shah, Hemendra, Shah, Shetal N., Shah, Zarine K., Shetty, Anup, Shiehmorteza, Masoud, Sirlin, Claude B., Small, William, Soto, Jorge A., Stein, Lance L., Surabhi, Venkateswar R., Testoni, Marco, Thabet, Ashraf, Thomas, Stephen, Tomei, Ernesto, Tsai, Richard, Udeshi, Michelle, Uppot, Raul N., Vaidya, Sujit, Viswamitra, Sanjaya, Walker, T. Gregory, and Yokoo, Takeshi

Published
2017
Full Text
View/download PDF

23. READERS WRITE

Author

Owens, Jennifer, Smith, Henry, Haynes, David, Noble, Ralph, Bowen, Bob, and Stein, Lance L.

Subjects
General interest, News, opinion and commentary
Abstract

Voter ID: League's stance unchanged In a recent article, Glenn Richardson (R-Hiram) wrote that 'Elisabeth MacNamara, president of the League of Women Voters of Georgia, opined that the law could [...]

Published
2006

26. Drug Targets in Hepatitis B Virus Infection

Author

Stein, Lance L. and Loomba, Rohit

Abstract

Hepatitis B virus infection (HBV) is a significant global health problem. Despite the success of universal hepatitis B vaccination in many countries, more than 350 million individuals worldwide are chronically infected and 15- 40% of those will develop cirrhosis and/or hepatocellular carcinoma if left untreated. Available therapies for chronic hepatitis B (CHB) infection are effective at decreasing viremia and improving measured clinical outcomes, however, no single therapy is optimal. As such, alternative drug therapies and the investigation of their role in the management of CHB are warranted. Significant improvements in the understanding of the HBV life cycle, viral genomics, and virus-host interactions continue to lead to the development of novel viral targets and immune modulators. Currently, two major classes of agents are utilized in CHB: the interferons and the nucleos(t)ide analogues. Each agent has individual advantages and drawbacks. The development of specific antiviral therapy has led to the emergence of HBV drug-resistant strains that has limited the long-term therapeutic potential of available agents. This necessitates the development of new agents that target both wild-type and drug-resistant strains. Further understanding of the basic mechanisms and clinical nuances of drug therapy is warranted. As most novel therapies are in the earliest stages of clinical development and testing, in the near future, treatment will continue to be long-term and likely involve the use of combination therapies to prevent viral resistance. In this review, we will highlight the HBV life cycle and genome, focusing in on current and potential novel antiviral drug targets as well as the benefits and clinical challenges with these therapies.

Published
2009

27. Drug targets in hepatitis B virus infection.

Author

Stein LL and Loomba R

Subjects
Antiviral Agents chemistry, Hepatitis B Vaccines therapeutic use, Hepatitis B virus growth & development, Hepatitis B virus physiology, Humans, Immunologic Factors therapeutic use, Interferons pharmacology, Interferons therapeutic use, Nucleic Acid Synthesis Inhibitors, RNA, Small Interfering therapeutic use, Reverse Transcriptase Inhibitors therapeutic use, T-Lymphocytes, Cytotoxic immunology, T-Lymphocytes, Cytotoxic physiology, Vaccination, Antiviral Agents pharmacology, Antiviral Agents therapeutic use, Hepatitis B drug therapy, Hepatitis B virus drug effects
Abstract

Hepatitis B virus infection (HBV) is a significant global health problem. Despite the success of universal hepatitis B vaccination in many countries, more than 350 million individuals worldwide are chronically infected and 15- 40% of those will develop cirrhosis and/or hepatocellular carcinoma if left untreated. Available therapies for chronic hepatitis B (CHB) infection are effective at decreasing viremia and improving measured clinical outcomes, however, no single therapy is optimal. As such, alternative drug therapies and the investigation of their role in the management of CHB are warranted. Significant improvements in the understanding of the HBV life cycle, viral genomics, and virus-host interactions continue to lead to the development of novel viral targets and immune modulators. Currently, two major classes of agents are utilized in CHB: the interferons and the nucleos(t)ide analogues. Each agent has individual advantages and drawbacks. The development of specific antiviral therapy has led to the emergence of HBV drug-resistant strains that has limited the long-term therapeutic potential of available agents. This necessitates the development of new agents that target both wild-type and drug-resistant strains. Further understanding of the basic mechanisms and clinical nuances of drug therapy is warranted. As most novel therapies are in the earliest stages of clinical development and testing, in the near future, treatment will continue to be long-term and likely involve the use of combination therapies to prevent viral resistance. In this review, we will highlight the HBV life cycle and genome, focusing in on current and potential novel antiviral drug targets as well as the benefits and clinical challenges with these therapies.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results